The role of Epstein-Barr virus in Hodgkin's disease from different geographical areas.
Open Access
- 1 January 1996
- journal article
- review article
- Published by BMJ in Archives of Disease in Childhood
- Vol. 74 (1) , 27-31
- https://doi.org/10.1136/adc.74.1.27
Abstract
Recent studies have suggested that Epstein-Barr virus (EBV) may play a role in the aetiology of Hodgkin's disease. To determine the role of EBV in childhood Hodgkin's disease in different geographical areas, immunohistochemical staining and in situ hybridisation were used to analyse latent membrane protein 1 (LMP 1) and small nuclear non-transcribed RNAs (EBER-1) respectively. Testing for EBV within the Reed-Sternberg and Hodgkin's cells was carried out in childhood Hodgkin's disease from 10 different countries. The proportion of LMP 1 positive cases varied significantly, being 50% of cases from the United Kingdom (38/75), South Africa (9/18), Egypt (7/14), and Jordan (8/16), 60% from the United Arab Emirates (6/10), 70% from Australia (11/16), 81% from Costa Rica (34/42), 88% from Iran (7/8), 90% from Greece (20/22), and 100% of the 56 cases from Kenya. A sensitive polymerase chain reaction based EBV strain typing technique was established using archival tissues. EBV strain type 1 was shown to be predominant in childhood Hodgkin's disease from the United Kingdom, South Africa, Australia, and Greece. Type 2 was predominant in Egypt. EBV strain types 1 and 2 were both detected in some cases of childhood Hodgkin's disease in the United Kingdom, Costa Rica, and Kenya. The high incidence of EBV and the presence especially in developing countries of dual infection with both strain types 1 and 2 may reflect socioeconomic conditions leading to malnutrition induced immunological impairment. The possibility of HIV infection also needs to be explored.Keywords
This publication has 35 references indexed in Scilit:
- Epstein‐barr virus (EBV) latent membrane protein (LMP) in tumor cells of Hodgkin's disease in pediatric patientsMedical and Pediatric Oncology, 1995
- The role of Epstein‐Barr virus in the pathogenesis of Hodgkin's diseaseThe Journal of Pathology, 1994
- Detection of Epstein‐Barr virus in Reed‐Sternberg cells of Hodgkin's disease arising in childrenMedical and Pediatric Oncology, 1993
- Description of an In Situ Hybridization Methodology for Detection of Epstein-Barr Virus RNA in Paraffin-Embedded Tissues, with a Survey of Normal and Neoplastic TissuesDiagnostic Molecular Pathology, 1992
- Immunohistochemical demonstration of the Epstein–Barr virus‐encoded latent membrane protein in paraffin sections of Hodgkin's diseaseThe Journal of Pathology, 1992
- Induction of bcl-2 expression by epstein-barr virus latent membrane protein 1 protects infected B cells from programmed cell deathCell, 1991
- Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's diseaseThe Lancet, 1991
- DETECTION OF A SECOND WIDESPREAD STRAIN OF EPSTEIN-BARR VIRUSThe Lancet, 1989
- Monoclonal Antibodies to the Latent Membrane Protein of Epstein-Barr Virus Reveal Heterogeneity of the Protein and Inducible Expression in Virus-transformed CellsJournal of General Virology, 1987
- Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes).Journal of Histochemistry & Cytochemistry, 1984